New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2014
10:43 EDTRTRXBroadfin Capital reports 6.93% passive stake in Retrophin
News For RTRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 24, 2014
15:22 EDTRTRXRetrophin founder Shkreli sells 1.172M shares
Martin Shkreli, the founder, former CEO and 10% shareholder of Retrophin, sold 1.172M shares of the company's stock in several transactions between November 14 and November 21 at prices ranging from about $8.23 to about $10.23, according to a regulatory filing.
November 19, 2014
15:30 EDTRTRXRetrophin founder Shkreli selling stake to fund new company, Feuerstein says
Martin Shkreli, the founder and former CEO of Retrophin, is selling his stake in the company as he tries to raise $50M of funding for a new company, Turing Pharma, reported TheStreet's Adam Feuerstein, citing sources. Reference Link
November 17, 2014
08:06 EDTRTRXRetrophin names Laura Clague as CFO
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use